DRN-CDR:一种使用多omics和药物特征的癌症药物反应预测模型
1Department of Computer Science and IT, School of Computing, Amrita Vishwa Vidyapeetham, Kochi Campus, India.
Computational biology and chemistry
|August 27, 2024
概括
本研究引入了用于癌症药物反应 (CDR) 预测的深度ResNet模型,集成多omics数据以个性化癌症治疗. 该模型准确预测药物的疗效,识别有效的抗癌剂.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 个性化癌症治疗需要准确预测癌症药物反应 (CDR).
- 整合多omics数据 (基因表达,突变,甲基化) 与药物分子结构用于CDR预测仍然是一个重大挑战.
- 深度学习方法提供了潜力,但需要有效的特征提取和整合策略.
研究的目的:
- 提出一种新的回归方法,即CDR (DRN-CDR) 的深度响应网络,用于预测药物疗效.
- 探索单独的癌症基因在提高CDR预测准确性的实用性.
- 整合多种数据类型,包括多omics和药物分子信息,以进行强大的CDR预测.
主要方法:
- 利用统一图形卷积网络用于药物特征提取和卷积神经网络/完全连接网络用于细胞系特征提取.
- 综合基因表达,突变和甲基化数据与药物分子结构.
- 采用Deep ResNet架构,根据连接的特征预测药物向相互作用 (IC50值).
主要成果:
- 实现了0.7938的高皮尔森相关系数 (rp) 和0.92的低根平均平方误差 (RMSE),超过了现有方法.
- 在分类任务中表现出强的表现,AUC和AUPR的指标分别为0.7623和0.7691.
- 通过对TCGA癌症类型的案例研究,确定了几种有效的抗癌药物,包括Tivozanib,SNX-2112和Foretinib.
结论:
- 该DRN-CDR模型有效地整合了多omics和药物结构数据,以准确预测CDR.
- 该模型识别强效抗癌药物的能力突显了其在个性化癌症治疗中的临床相关性.
- 这种方法通过提高药物反应预测准确度,促进了深度学习在精确瘤学的应用.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
4.8K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334